Teaching hospital Program year 2025 Source: CMS Open Payments

Brigham and Womens Hospital

MA

CCN 220110 CMS hospital 16235

Open in the dashboard

General payments

$66,268,961

2,377 payments

Research payments

$429,726,545

11,570 payments

Through program year 2025, Brigham and Womens Hospital is reported as receiving $66,268,961 in general payments and $429,726,545 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $10,831,970 225
2025 Research $49,015,800 1,619
2024 General $8,122,911 264
2024 Research $49,839,436 1,607
2023 General $8,309,358 301
2023 Research $51,540,917 2,282
2022 General $6,951,646 317
2022 Research $76,954,203 1,232
2021 General $13,433,175 315
2021 Research $53,421,987 1,674
2020 General $9,340,146 405
2020 Research $75,368,206 1,629
2019 General $9,279,755 550
2019 Research $73,585,996 1,527

Breakdown

Who paid General payments · program years 2019–2025
  1. Alnylam Pharmaceuticals Inc. $9,059,181 91 payments
  2. AstraZeneca Pharmaceuticals LP $8,085,608 45 payments
  3. Ucb SA $3,810,747 3 payments
  4. Bioverativ Therapeutics Inc. $3,116,394 1 payment
  5. Pfizer Inc. $2,812,611 60 payments
  6. InSightec,LTD $2,738,594 11 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $2,546,670 12 payments
  8. Amgen Inc. $2,215,188 21 payments
  9. Alexion Pharmaceuticals, Inc. $1,957,058 54 payments
  10. Kowa Company, Ltd. $1,759,990 3 payments
  11. Other $28,166,920 2,076 payments
What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,788,067 284 payments
  2. Grant $17,502,927 306 payments
  3. Royalty or License $10,025,246 611 payments
  4. Charitable Contribution $8,740,734 96 payments
  5. Consulting Fee $5,798,467 226 payments
  6. Space rental or facility fees (teaching hospital only) $2,883,715 215 payments
  7. Education $1,206,774 281 payments
  8. Long term medical supply or device loan $865,228 114 payments
  9. Gift $262,586 175 payments
  10. Debt forgiveness $134,385 61 payments
  11. Other $60,833 8 payments
Products named General payments · program years 2019–2025
  1. Alprolix $3,116,394 1 payment
  2. Eloctate $3,116,394 1 payment
  3. Onpattro $2,696,912 24 payments
  4. Exablate Neurology $1,333,893 5 payments
  5. Xolair $1,019,000 10 payments
  6. Exablate Neurology $865,678 1 payment
  7. P-75 $650,000 2 payments
  8. Entresto $615,133 9 payments
  9. Savaysa $503,705 8 payments
  10. Tezspire $500,000 2 payments
  11. Other $10,338,519 1,370 payments

A payment can name more than one product, so these amounts overlap.

2,377 general · 11,570 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record